Maven Securities’s Medtronic MDT Stock Holding History

Maven Securities’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,462	Closed	-$463K	–	902
2025 Q1	$491K	Sell	5,462 -262	-5%	-$23.4K	0.02%	600
2024 Q4	$457K	Buy	+5,724	New	+$496K	0.01%	602
2024 Q3	–	Sell	-9,934	Closed	-$836K	–	1005
2024 Q2	$782K	Buy	+9,934	New	+$814K	0.02%	580
2023 Q4	–	Sell	-11,983	Closed	-$939K	–	1092
2023 Q3	$939K	Buy	+11,983	New	+$1M	0.01%	638
2022 Q4	–	Sell	-10,064	Closed	-$816K	–	1009
2022 Q3	$813K	Buy	10,064 +7,084	+238%	+$637K	0.02%	620
2022 Q2	$267K	Buy	2,980 +427	+17%	+$43.3K	0.01%	776
2022 Q1	$283K	Buy	+2,553	New	+$270K	0.01%	719
2021 Q3	–	Sell	-1,664	Closed	-$207K	–	1182
2021 Q2	$207K	Buy	+1,664	New	+$209K	0.01%	935
2021 Q1	–	Sell	-1,751	Closed	-$205K	–	1249
2020 Q4	$205K	Buy	+1,751	New	+$193K	0.02%	506
2020 Q2	–	Sell	-2,255	Closed	-$216K	–	550
2020 Q1	$203K	Buy	+2,255	New	+$240K	0.02%	280

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maven Securities's MDT Position: Q2 2025 in Review

Maven Securities sold out of Medtronic (MDT) in Q2 2025, closing a stake of 5,462 shares — an estimated $463K sold.

Maven Securities first reported a position in MDT in Q1 2020 and held it in 10 quarters. The position peaked at $939K in Q3 2023. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Maven Securities reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
Maven Securities sold 5,462 Medtronic shares in Q2 2025, an estimated $463K.
Maven Securities first reported a position in Medtronic in Q1 2020 and held it in 10 quarters.
Maven Securities's Medtronic position peaked at $939K in Q3 2023.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.